24 research outputs found

    Flight trajectory optimization of Fly-Gen airborne wind energy systems through a harmonic balance method

    Get PDF
    The optimal control problem for flight trajectories of Fly-Gen airborne wind energy systems (AWESs) is a crucial research topic for the field, as suboptimal paths can lead to a drastic reduction in power production. One of the novelties of the present work is the expression of the optimal control problem in the frequency domain through a harmonic balance formulation. This allows the potential reduction of the problem size by solving only for the main harmonics and allows the implicit imposition of periodicity of the solution. The trajectory is described by the Fourier coefficients of the dynamics (elevation and azimuth angles) and of the control inputs (onboard wind turbine thrust and AWES roll angle). To isolate the effects of each physical phenomenon, optimal trajectories are presented with an increasing level of physical representation from the most idealized case: (i) if the mean thrust power (mechanical power linked to the dynamics) is considered as the objective function, optimal trajectories are characterized by a constant AWES velocity over the loop and a circular shape. This is done by converting all the gravitational potential energy into electrical energy. At low wind speed, onboard wind turbines are then used as propellers in the ascendant part of the loop; (ii) if the mean shaft power (mechanical power after momentum losses) is the objective function, a part of the potential energy is converted into kinetic and the rest into electrical energy. Therefore, the AWES velocity fluctuates over the loop; (iii) if the mean electrical power is considered as the objective function, the onboard wind turbines are never used as propellers because of the power conversion efficiency. Optimal trajectories for case (ii) and (iii) have a circular shape squashed along the vertical direction. The optimal control inputs can be generally modeled with one harmonic for the onboard wind turbine thrust and two for AWES roll angle without a significant loss of power, demonstrating that the absence of high-frequency control is not detrimental to the power generated by Fly-Gen AWESs.The work by PoliMI had no external funding and was therefore self-funded by the research team. The work by ICF was carried out under the framework of the GreenKite-2 project (PID2019-110146RB-I00) funded by MCIN/AEI/10.13039/501100011033

    Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration

    Get PDF
    Pulmonary Arterial Hypertension (PAH) is a rare and devasting condition characterized by elevated pulmonary vascular resistance and pulmonary artery pressure leading to right-heart failure and premature death. Pathologic alterations in proliferation, migration and survival of all cell types composing the vascular tissue play a key role in the occlusion of the vascular lumen. In the current study, we initially investigated the action of selective class I and class II HDAC inhibitors on the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) after exposure to Platelet Derived Growth Factor (PDGF). Class I HDAC inhibitors were able to counteract the hyperproliferative response to PDGF, reducing both proliferation and migration in PASMCs, while class II were ineffective. Selective silencing with siRNAs targeted against different HDACs revealed a major role of class I, and within this class, of HDAC1 in mediating PDGF-induced Akt Phosphorylation and Cyclin D1 (CycD1) expression. These results from these combinatorial approaches were further confirmed by the ability of a specific HDAC1 inhibitor to antagonize the PDGF action. The finding that HDAC1 is a major conductor of PDGF-induced patterning in PAH-PASMCs prompts the development of novel selective inhibitors of this member of class I HDACs as a potential tool to control lung vascular homeostasis in PAH

    Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)

    Get PDF
    : Clear cell sarcoma of the kidney (CCSK) is a rare pediatric renal tumor with a worse prognosis than Wilms' tumor. Although recently, BCOR internal tandem duplication (ITD) has been found as a driver mutation in more than 80% of cases, a deep molecular characterization of this tumor is still lacking, as well as its correlation with the clinical course. The aim of this study was to investigate the differential molecular signature between metastatic and localized BCOR-ITD-positive CCSK at diagnosis. Whole-exome sequencing (WES) and whole-transcriptome sequencing (WTS) were performed on six localized and three metastatic BCOR-ITD-positive CCSKs, confirming that this tumor carries a low mutational burden. No significant recurrences of somatic or germline mutations other than BCOR-ITD were identified among the evaluated samples. Supervised analysis of gene expression data showed enrichment of hundreds of genes, with a significant overrepresentation of the MAPK signaling pathway in metastatic cases (p < 0.0001). Within the molecular signature of metastatic CCSK, five genes were highly and significantly over-expressed: FGF3, VEGFA, SPP1, ADM, and JUND. The role of FGF3 in the acquisition of a more aggressive phenotype was investigated in a cell model system obtained by introducing the ITD into the last exon of BCOR by Crispr/Cas9 gene editing of the HEK-293 cell line. Treatment with FGF3 of BCOR-ITD HEK-293 cell line induced a significant increase in cell migration versus both untreated and scramble cell clone. The identification of over-expressed genes in metastatic CCSKs, with a particular focus on FGF3, could offer new prognostic and therapeutic targets in more aggressive cases

    A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

    Get PDF
    : The clinical manifestations of SARS-CoV-2 infection vary widely among patients, from asymptomatic to life-threatening. Host genetics is one of the factors that contributes to this variability as previously reported by the COVID-19 Host Genetics Initiative (HGI), which identified sixteen loci associated with COVID-19 severity. Herein, we investigated the genetic determinants of COVID-19 mortality, by performing a case-only genome-wide survival analysis, 60 days after infection, of 3904 COVID-19 patients from the GEN-COVID and other European series (EGAS00001005304 study of the COVID-19 HGI). Using imputed genotype data, we carried out a survival analysis using the Cox model adjusted for age, age2, sex, series, time of infection, and the first ten principal components. We observed a genome-wide significant (P-value < 5.0 × 10-8) association of the rs117011822 variant, on chromosome 11, of rs7208524 on chromosome 17, approaching the genome-wide threshold (P-value = 5.19 × 10-8). A total of 113 variants were associated with survival at P-value < 1.0 × 10-5 and most of them regulated the expression of genes involved in immune response (e.g., CD300 and KLR genes), or in lung repair and function (e.g., FGF19 and CDH13). Overall, our results suggest that germline variants may modulate COVID-19 risk of death, possibly through the regulation of gene expression in immune response and lung function pathways

    Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19

    Get PDF
    Thrombosis of small and large vessels is reported as a key player in COVID-19 severity. However, host genetic determinants of this susceptibility are still unclear. Congenital Thrombotic Thrombocytopenic Purpura is a severe autosomal recessive disorder characterized by uncleaved ultra-large vWF and thrombotic microangiopathy, frequently triggered by infections. Carriers are reported to be asymptomatic. Exome analysis of about 3000 SARS-CoV-2 infected subjects of different severities, belonging to the GEN-COVID cohort, revealed the specific role of vWF cleaving enzyme ADAMTS13 (A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13). We report here that ultra-rare variants in a heterozygous state lead to a rare form of COVID-19 characterized by hyper-inflammation signs, which segregates in families as an autosomal dominant disorder conditioned by SARS-CoV-2 infection, sex, and age. This has clinical relevance due to the availability of drugs such as Caplacizumab, which inhibits vWF-platelet interaction, and Crizanlizumab, which, by inhibiting P-selectin binding to its ligands, prevents leukocyte recruitment and platelet aggregation at the site of vascular damage

    Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes

    Get PDF
    Carriers of single pathogenic variants of the CFTR (cystic fibrosis transmembrane conductance regulator) gene have a higher risk of severe COVID-19 and 14-day death. The machine learning post-Mendelian model pinpointed CFTR as a bidirectional modulator of COVID-19 outcomes. Here, we demonstrate that the rare complex allele [G576V;R668C] is associated with a milder disease via a gain-of-function mechanism. Conversely, CFTR ultra-rare alleles with reduced function are associated with disease severity either alone (dominant disorder) or with another hypomorphic allele in the second chromosome (recessive disorder) with a global residual CFTR activity between 50 to 91%. Furthermore, we characterized novel CFTR complex alleles, including [A238V;F508del], [R74W;D1270N;V201M], [I1027T;F508del], [I506V;D1168G], and simple alleles, including R347C, F1052V, Y625N, I328V, K68E, A309D, A252T, G542*, V562I, R1066H, I506V, I807M, which lead to a reduced CFTR function and thus, to more severe COVID-19. In conclusion, CFTR genetic analysis is an important tool in identifying patients at risk of severe COVID-19

    Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features

    Get PDF
    The impact of common and rare variants in COVID-19 host genetics has been widely studied. In particular, in Fallerini et al. (Human genetics, 2022, 141, 147–173), common and rare variants were used to define an interpretable machine learning model for predicting COVID-19 severity. First, variants were converted into sets of Boolean features, depending on the absence or the presence of variants in each gene. An ensemble of LASSO logistic regression models was used to identify the most informative Boolean features with respect to the genetic bases of severity. After that, the Boolean features, selected by these logistic models, were combined into an Integrated PolyGenic Score (IPGS), which offers a very simple description of the contribution of host genetics in COVID-19 severity.. IPGS leads to an accuracy of 55%–60% on different cohorts, and, after a logistic regression with both IPGS and age as inputs, it leads to an accuracy of 75%. The goal of this paper is to improve the previous results, using not only the most informative Boolean features with respect to the genetic bases of severity but also the information on host organs involved in the disease. In this study, we generalize the IPGS adding a statistical weight for each organ, through the transformation of Boolean features into “Boolean quantum features,” inspired by quantum mechanics. The organ coefficients were set via the application of the genetic algorithm PyGAD, and, after that, we defined two new integrated polygenic scores (IPGSph1 and IPGSph2). By applying a logistic regression with both IPGS, (IPGSph2 (or indifferently IPGSph1) and age as inputs, we reached an accuracy of 84%–86%, thus improving the results previously shown in Fallerini et al. (Human genetics, 2022, 141, 147–173) by a factor of 10%

    Flight trajectory optimization of Fly-Gen airborne wind energy systems through a harmonic balance method

    Get PDF
    The optimal control problem for flight trajectories of Fly-Gen airborne wind energy systems (AWESs) is a crucial research topic for the field, as suboptimal paths can lead to a drastic reduction in power production. One of the novelties of the present work is the expression of the optimal control problem in the frequency domain through a harmonic balance formulation. This allows the potential reduction of the problem size by solving only for the main harmonics and allows the implicit imposition of periodicity of the solution. The trajectory is described by the Fourier coefficients of the dynamics (elevation and azimuth angles) and of the control inputs (onboard wind turbine thrust and AWES roll angle). To isolate the effects of each physical phenomenon, optimal trajectories are presented with an increasing level of physical representation from the most idealized case: (i) if the mean thrust power (mechanical power linked to the dynamics) is considered as the objective function, optimal trajectories are characterized by a constant AWES velocity over the loop and a circular shape. This is done by converting all the gravitational potential energy into electrical energy. At low wind speed, onboard wind turbines are then used as propellers in the ascendant part of the loop; (ii) if the mean shaft power (mechanical power after momentum losses) is the objective function, a part of the potential energy is converted into kinetic and the rest into electrical energy. Therefore, the AWES velocity fluctuates over the loop; (iii) if the mean electrical power is considered as the objective function, the onboard wind turbines are never used as propellers because of the power conversion efficiency. Optimal trajectories for case (ii) and (iii) have a circular shape squashed along the vertical direction. The optimal control inputs can be generally modeled with one harmonic for the onboard wind turbine thrust and two for AWES roll angle without a significant loss of power, demonstrating that the absence of high-frequency control is not detrimental to the power generated by Fly-Gen AWESs.The work by PoliMI had no external funding and was therefore self-funded by the research team. The work by ICF was carried out under the framework of the GreenKite-2 project (PID2019-110146RB-I00) funded by MCIN/AEI/10.13039/501100011033
    corecore